Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma
JOURNAL OF ASTHMA, vol.59, no.3, pp.580-589, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 59 Issue: 3
- Publication Date: 2022
- Doi Number: 10.1080/02770903.2020.1861626
- Journal Name: JOURNAL OF ASTHMA
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Psycinfo, Veterinary Science Database
- Page Numbers: pp.580-589
- Keywords: Quality of Life, treatment, pediatrics, pharmacotherapy
- Gazi University Affiliated: Yes
Abstract
Introduction: Montelukast-induced neuropsychiatric adverse drug reactions (ADRs) have been reported in retrospective studies. This study aimed to reveal the neuropsychiatric ADRs triggered in patients taking montelukast due to asthma in real time, and to evaluate the effect of these ADRs on quality of life (QoL).